Association of circulating hsa-miRNAs with sarcopenia: the SarcoPhAge study.
Circulating hsa-miRNAs
Next generation sequencing
Sarcopenia
TaqMan qPCR
Journal
Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995
Informations de publication
Date de publication:
14 Mar 2024
14 Mar 2024
Historique:
received:
10
08
2023
accepted:
23
01
2024
medline:
18
3
2024
pubmed:
15
3
2024
entrez:
15
3
2024
Statut:
epublish
Résumé
To identify a microRNA signature associated to sarcopenia in community-dwelling older adults form the SarcoPhAge cohort. In a screening phase by next generation sequencing (NGS), we compared the hsa-miRome expression of 18 subjects with sarcopenia (79.6 ± 6.8 years, 9 men) and 19 healthy subjects without sarcopenia (77.1 ± 6 years, 9 men) at baseline. Thereafter, we have selected eight candidate hsa-miRNAs according to the NGS results and after a critical assessment of previous literature. In a validation phase and by real-time qPCR, we then analyzed the expression levels of these 8 hsa-miRNAs at baseline selecting 92 healthy subjects (74.2 ± 10 years) and 92 subjects with sarcopenia (75.3 ± 6.8 years). For both steps, the groups were matched for age and sex. In the validation phase, serum has-miRNA-133a-3p and has-miRNA-200a-3p were significantly decreased in the group with sarcopenia vs controls [RQ: relative quantification; median (interquartile range)]: -0.16 (-1.26/+0.90) vs +0.34 (-0.73/+1.33) (p < 0.01) and -0.26 (-1.07/+0.68) vs +0.27 (-0.55/+1.10) (p < 0.01) respectively. Has-miRNA-744-5p was decreased and has-miRNA-151a-3p was increased in the group with sarcopenia vs controls, but this barely reached significance: +0.16 (-1.34/+0.79) vs +0.44 (-0.31/+1.00) (p = 0.050) and +0.35 (-0.22/+0.90) vs +0.03 (-0.68/+0.75) (p = 0.054). In subjects with sarcopenia, serum hsa-miRNA-133a-3p and hsa-miRNA-200a-3p expression were downregulated, consistent with their potential targets inhibiting muscle cells proliferation and differentiation.
Identifiants
pubmed: 38485856
doi: 10.1007/s40520-024-02711-z
pii: 10.1007/s40520-024-02711-z
pmc: PMC10940485
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
70Informations de copyright
© 2024. The Author(s).
Références
Oncotarget. 2017 Feb 7;8(6):10662-10674
pubmed: 27793012
Open Med (Wars). 2022 Sep 24;17(1):1515-1527
pubmed: 36237831
Clin Epigenetics. 2017 Dec 12;9:127
pubmed: 29255496
Mol Med Rep. 2020 Apr 24;:
pubmed: 32626937
Front Genet. 2020 Mar 05;11:167
pubmed: 32194634
Int J Clin Exp Pathol. 2021 Sep 15;14(9):972-979
pubmed: 34646415
BMC Geriatr. 2021 Jan 30;21(1):86
pubmed: 33516190
Exp Gerontol. 2015 Sep;69:103-10
pubmed: 25979160
Front Physiol. 2021 Jun 07;12:678610
pubmed: 34163374
Cell Cycle. 2022 Jun;21(11):1212-1221
pubmed: 35244512
J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31
pubmed: 10811152
J Bone Miner Res. 2020 Oct;35(10):1881-1892
pubmed: 32526052
Aging Cell. 2012 Feb;11(1):29-40
pubmed: 21981419
Age Ageing. 2011 Jul;40(4):423-9
pubmed: 21624928
EMBO Mol Med. 2020 Jan 9;12(1):e11019
pubmed: 31793167
Open Med (Wars). 2021 Nov 03;16(1):1642-1652
pubmed: 34761115
J Bone Miner Res. 2023 Nov;38(11):1665-1678
pubmed: 37715362
Exp Ther Med. 2020 Dec;20(6):239
pubmed: 33193844
J Biol Chem. 2015 Jan 30;290(5):2831-41
pubmed: 25505246
Ann Rheum Dis. 2015 Mar;74(3):e18
pubmed: 24515954
Cardiovasc Res. 2020 Jun 1;116(7):1386-1397
pubmed: 31504257
Oncotarget. 2016 Jan 5;7(1):33-45
pubmed: 26683101
Osteoarthritis Cartilage. 2012 Dec;20(12):1631-7
pubmed: 22944527
Int Immunopharmacol. 2023 Jan;114:109611
pubmed: 36700779
Bioengineered. 2022 May;13(5):12985-12997
pubmed: 35611851
Am J Transl Res. 2017 Jun 15;9(6):2852-2864
pubmed: 28670374
Ageing Res Rev. 2015 Nov;24(Pt B):263-73
pubmed: 26342566
Glob Heart. 2021 Aug 30;16(1):56
pubmed: 34692380
PLoS One. 2014 Jun 05;9(6):e97690
pubmed: 24901787
J Cell Physiol. 2015 May;230(5):1003-12
pubmed: 25200835
Exp Ther Med. 2021 Jun;21(6):589
pubmed: 33850561
Am J Epidemiol. 1998 Apr 15;147(8):755-63
pubmed: 9554417
Physiol Res. 2021 Nov 30;70(Suppl 1):S91-S98
pubmed: 35503054
Arthritis Res Ther. 2020 Jan 2;22(1):2
pubmed: 31898522
Age Ageing. 2019 Jul 1;48(4):601
pubmed: 31081853
Mol Ther Nucleic Acids. 2019 Jun 7;16:481-493
pubmed: 31051333
Life Sci. 2021 Nov 15;285:119926
pubmed: 34480932
J Anim Sci. 2013 Jan;91(1):90-103
pubmed: 23100578
Gene. 2017 Aug 20;625:49-54
pubmed: 28483596
Cell J. 2022 Nov 02;24(11):673-680
pubmed: 36377217
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Gene. 2017 Sep 5;627:194-201
pubmed: 28627440
Pflugers Arch. 2021 Feb;473(2):231-240
pubmed: 33420548
Calcif Tissue Int. 2017 Mar;100(3):229-234
pubmed: 28012107
Int J Biol Macromol. 2022 Dec 1;222(Pt B):2212-2224
pubmed: 36208808
Bone. 2019 Mar;120:271-278
pubmed: 30408612
Osteoarthritis Cartilage. 2016 Sep;24(9):1577-86
pubmed: 27143365
Biomed Pharmacother. 2017 Nov;95:983-989
pubmed: 28922712
Int J Mol Sci. 2020 May 05;21(9):
pubmed: 32380777
Can J Physiol Pharmacol. 2020 May;98(5):314-323
pubmed: 32268073
Pathol Res Pract. 2022 May;233:153858
pubmed: 35364459
Nutrients. 2020 Jan 22;12(2):
pubmed: 31979011
Comput Math Methods Med. 2021 Mar 6;2021:6680211
pubmed: 33747117
Int J Mol Sci. 2020 Jul 04;21(13):
pubmed: 32635504
Curr Med Sci. 2018 Apr;38(2):245-251
pubmed: 30074182
BMC Cardiovasc Disord. 2021 Aug 2;21(1):371
pubmed: 34340677
Geriatr Gerontol Int. 2019 Mar;19(3):272
pubmed: 30821065
Int J Mol Sci. 2022 Sep 06;23(18):
pubmed: 36142173
J Cell Biol. 2008 Feb 25;180(4):787-802
pubmed: 18299349
Can Respir J. 2022 Dec 5;2022:5933324
pubmed: 36518817
Nat Genet. 2006 Feb;38(2):228-33
pubmed: 16380711
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):86-99
pubmed: 34816624
Exerc Sport Sci Rev. 2018 Apr;46(2):86-91
pubmed: 29346160
Allergy Asthma Clin Immunol. 2022 Oct 2;18(1):88
pubmed: 36184652
Calcif Tissue Int. 2023 Feb;112(2):197-217
pubmed: 36633611
J Cardiovasc Pharmacol. 2020 Oct;76(4):427-436
pubmed: 33027196
Circ Res. 2019 Apr 26;124(9):1386-1400
pubmed: 30879399
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4218-23
pubmed: 20142475